ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
97 hedge funds and large institutions have $207M invested in Adamas Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 26 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
66% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 41
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
97
Holding in Top 10
1
Calls
$2.47M
Puts
$462K
Top Buyers
| 1 | +$11M | |
| 2 | +$7.88M | |
| 3 | +$5.62M | |
| 4 |
Morgan Stanley
New York
|
+$4.32M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$3.24M |
Top Sellers
| 1 | -$18.2M | |
| 2 | -$12.3M | |
| 3 | -$10.2M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$8.45M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$6.92M |